Arcutis Biotherapeutics【ARQT】株式ニュース

名称	銘柄コード	市場	種別
Arcutis Biotherapeutics Inc	ARQT	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.36	-4.74%	7.24	06:02:00

始値	安値	高値	終値	前日終値
7.48	7.22	7.525	7.24	7.60

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/07	05:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	05:00	GLOBE	Arcutis Biotherapeutics Reports Inducement Grants Under..
2024/6/05	21:00	GLOBE	Arcutis Announces Multiple Abstracts, Including Oral..
2024/6/05	03:03	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/03	21:00	GLOBE	Arcutis to Present at the Goldman Sachs 45th Annual Global..
2024/5/30	08:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/29	04:54	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/28	20:00	PRNCA	Arcutis Canada annonce l'acceptation aux fins d'examen par..
2024/5/21	06:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	04:58	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/15	05:06	EDGAR2	Form 8-K - Current report
2024/5/15	05:00	GLOBE	Arcutis Announces First Quarter 2024 Financial Results and..
2024/5/14	20:18	IHMARKETNEWS	US Futures Remain Steady Amid Wall Street Caution Ahead of..
2024/5/13	21:00	GLOBE	Expert Panel Review Further Validates Use of ZORYVE®..
2024/5/04	05:00	GLOBE	Arcutis Biotherapeutics Reports Inducement Grants Under..
2024/4/30	05:00	GLOBE	Arcutis to Report First Quarter 2024 Financial Results..
2024/4/10	21:00	GLOBE	Arcutis Appoints David Topper as Chief Financial Officer
2024/4/06	05:00	GLOBE	Arcutis Biotherapeutics Reports Inducement Grants Under..
2024/4/01	20:00	GLOBE	Sol-Gel’s Collaboration Partner First-to-File ANDA Drug..
2024/3/28	21:00	GLOBE	Arcutis to Present at the 23rd Annual Needham Virtual..
2024/3/11	21:00	GLOBE	Arcutis Promotes Todd Tucker to Chief Human Resources..
2024/3/11	05:00	GLOBE	Arcutis Presents Late-Breaking Data From INTEGUMENT-PED..
2024/3/10	06:00	GLOBE	New Research Reveals Genomic Profile of Seborrheic..
2024/3/07	07:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	07:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	07:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	06:00	GLOBE	Arcutis Biotherapeutics Reports Inducement Grants Under..
2024/3/05	07:47	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	07:42	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	07:40	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	06:10	EDGAR2	Form 8-K - Current report
2024/3/05	06:00	GLOBE	Arcutis Announces Closing of Public Offering of Common Stock..
2024/3/04	22:00	GLOBE	Arcutis Announces Acceptance of Late Breaking Abstract in..
2024/3/02	06:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/02	06:06	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/01	07:00	GLOBE	Arcutis to Present at the TD Cowen 44th Annual Health Care..
2024/2/29	13:30	GLOBE	Arcutis Announces Pricing of $150 Million Public Offering
2024/2/29	06:54	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/29	06:21	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/29	06:10	EDGAR2	Form 8-K - Current report
2024/2/29	06:10	GLOBE	Arcutis Announces Proposed Public Offering
2024/2/29	06:00	GLOBE	Arcutis and Sato Announce Strategic Collaboration and..
2024/2/28	06:34	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/2/27	21:48	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/27	21:44	EDGAR2	Form 8-K - Current report
2024/2/27	19:50	GLOBE	Arcutis Announces Fourth Quarter and Full Year 2023..
2024/2/16	22:00	GLOBE	Arcutis to Report Fourth Quarter and Full Year 2023..
2024/2/16	08:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/16	08:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/16	08:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..